Oral Sarms GW501516 GSK-516 Muscle Building
1) Product Name: Cardarine / GW501516 CAS 317318-70-0
2) CAS: 317318-70-0
3) Specification: ≥99%
4) Appearance: Light yellow fine powder to White fine powder
W501516 (also known as GW-501,516, GW1516, GSK-516 and Endurobol)
is a PPARδ receptor. It activates the same pathways activated through exercise, including PPARδ and AMP-activated protein kinase. It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease. GW501516 has a synergistic effect when combined with AICAR: the combination has been shown to significantly increase exercise endurance in animal studies more than either compound alone.
1. GW 501516 is the “ultimate endurance enhancer” – It’s used by elite athletes and competitors for a reason.
2. Gives you insane energy levels – so you can push harder in the gym, increase your intensity, and bust through plateaus like never before.
3. Decreases recovery time – meaning you can lift almost every day while taking GW.
4. Will rapidly melt fat, but is NON CATABOLIC. That means you’ll keep all your gains while getting leaner.
5. Will get you immediate, noticeable results: literally on the first dose.
6. Provides one of the cleanest energies. It’s not a stimulant, so you won’t crash or feel anxious at all.
7. The ability to run for as long as 12 weeks. You’ll get better and better results the longer you take it.
8. Is versatile – can be stacked with virtually anything.
9. Can be used while cutting or bulking. Cardarine will accelerate your results no matter what you do.
10. Gives you an overall sense of health and well being. You’ll feel amazing while you’re on it.
11. No side effects, liver toxicity, or suppression have been reported. There’s no need for PCT either.
12. Called the possible cure for obesity, Cardarine allows you to lose weight by using fat stores for energy rather than carbohydrates.
GW501516 Cardarine Usages And Descriptions:
GW501516 (also known as GW-501,516, GW1516, GSK-516 and Endurobol)is a PPAR receptor.
It activates the same pathways activated through exercise, including PPAR and AMP-activated protein kinase. It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease. GW501516 has a synergistic effect when combined with AICAR: the combination has been shown to significantly increase exercise endurance in animal studies more than either compound .
An experimental drug meant to control lipids and increase the level of HDL, or good cholesterol, in the bloodstream. A cell-permeable, thiazolyl compound that acts as a potent, high affinity, PPAR agonist.
Exhibits selectivity for PPARo compared to PPAR and PPAR. Does not exibit any activity against other nuclear or non-nuclear receptors. Reported to increase cholesterol efflux and ABAC1 expression in macrophages, fibroblasts, and intestinal cells.
GW501516 could be used by athletes as an ergogenic performance enhancing drug that was not currently controlled by regulations or detected by standard tests. One of the main researchers from the study onenhanced endurance consequently developed a urine test to detect the drug, and made it available to the International Olympic Committee.
Packaging & Delivery
Packaging Details Cardarine packing :
1-5kg with ziplock plastic bag inside,Aluminum foil bag outside.finally with waterproof bag.
6-15kg with plastic bag inside,Aluminum foil bag outside,finally with carton box.
More than 16kg with plastic bag inside,fiber drum outside according to the extract quantity.Delivery TimeWithin 2 working days after receiving the payment
acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown
medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy.
for the treatment of frailty in the elderly
pharmacological profile similar to that of enobosarm, Ostarine,MK-2866
For obesity, diabetes, dyslipidemia and cardiovascular disease
partial agonist, intended mainly for treatment of benign prostatic hypertrophy
under development at The Scripps Research Institute (TSRI),increases the level of metabolic activity in skeletal muscles of mice
New generation for gaining mass and cutting edges
YK11: a SARM and myostatin inhibitor in one